Page last updated: 2024-09-05

tolvaptan and Dyspnea

tolvaptan has been researched along with Dyspnea in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (8.33)29.6817
2010's8 (66.67)24.3611
2020's3 (25.00)2.80

Authors

AuthorsStudies
Hirano, T; Kim, S; Kinugawa, K; Nakata, E1
Han, D; Shang, W; Zhang, Y1
Li, J; Yin, C; Yuan, L1
Chen, S; Du, R; Han, S; Li, J; Liu, M; Wang, L; Zhang, Q1
Cai, L; Wang, C; Xiong, B1
Abdulhadi, B; Mezue, K; Rangaswami, J1
Kajimoto, K; Otsubo, S1
Burnett, J; Gheorghiade, M; Grinfeld, L; Hauptman, PJ; Konstam, MA; Kostic, D; Krasa, HB; Maggioni, A; Ouyang, J; Swedberg, K; Udelson, JE; Zannad, F; Zimmer, C1
Ambrosy, AP; Butler, J; Chioncel, O; Gheorghiade, M; Greene, SJ; Khan, H; Konstam, MA; Maggioni, AP; Mentz, RJ; Subacuis, HP; Swedberg, K; Udelson, JE; Vaduganathan, M; Zannad, F1
Adams, KF; Cole, RT; Echols, M; Egnaczyk, GF; Felker, GM; Fiuzat, M; Gupta, D; Khouri, MG; Mentz, RJ; Monds, P; O'Connor, CM; Patel, CB; Roberts, R; Tauras, JM1
Chandler, A; Dhingra, R; Dowling, D; Eisen, H; Fileccia, R; Gordon, P; Gregory, D; Gupta, D; Haught, WH; Kiernan, M; Konstam, JM; Konstam, MA; Korr, K; Massaro, JM; Mody, FV; Patten, R; Pressler, SJ; Romeling, M; Udelson, JE; Wagoner, L; Wedge, P1
Blair, JE; Burnett, JC; Gheorghiade, M; Grinfeld, L; Konstam, MA; Krasa, HB; Maggioni, AP; Ouyang, J; Pang, PS; Swedberg, K; Teerlink, JR; Udelson, JE; Zannad, F; Zimmer, C1

Reviews

4 review(s) available for tolvaptan and Dyspnea

ArticleYear
Benefits of tolvaptan on early dyspnea relief in patients with acute heart failure: A meta-analysis.
    Clinical cardiology, 2022, Volume: 45, Issue:10

    Topics: Antidiuretic Hormone Receptor Antagonists; Dyspnea; Heart Failure; Humans; Tolvaptan

2022
Comment on: Benefits of tolvaptan on early dyspnea relief in patients with acute heart failure: A meta-analysis.
    Clinical cardiology, 2023, Volume: 46, Issue:5

    Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Dyspnea; Heart Failure; Humans; Tolvaptan

2023
Tolvaptan in reversing worsening acute heart failure: A systematic review and meta-analysis.
    The Journal of international medical research, 2019, Volume: 47, Issue:11

    Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Dyspnea; Heart Failure; Humans; Prognosis; Tolvaptan

2019
Effects of Tolvaptan in patients with acute heart failure: a systematic review and meta-analysis.
    BMC cardiovascular disorders, 2017, 06-20, Volume: 17, Issue:1

    Topics: Acute Disease; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Biomarkers; Dyspnea; Female; Heart Failure; Humans; Male; Middle Aged; Odds Ratio; Randomized Controlled Trials as Topic; Recovery of Function; Sodium; Time Factors; Tolvaptan; Treatment Outcome; Weight Loss

2017

Trials

5 trial(s) available for tolvaptan and Dyspnea

ArticleYear
Clinical course of patients with hyponatremia and decompensated systolic heart failure and the effect of vasopressin receptor antagonism with tolvaptan.
    Journal of cardiac failure, 2013, Volume: 19, Issue:6

    Topics: Aged; Analysis of Variance; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Diuretics; Dyspnea; Female; Furosemide; Heart Failure, Systolic; Humans; Hyponatremia; Male; Middle Aged; Proportional Hazards Models; Tolvaptan; Weight Loss

2013
Changes in Dyspnea Status During Hospitalization and Postdischarge Health-Related Quality of Life in Patients Hospitalized for Heart Failure: Findings From the EVEREST Trial.
    Circulation. Heart failure, 2016, Volume: 9, Issue:5

    Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cause of Death; Double-Blind Method; Dyspnea; Female; Health Status; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Patient Discharge; Patient Readmission; Predictive Value of Tests; Prospective Studies; Quality of Life; Recovery of Function; Risk Factors; Stroke Volume; Surveys and Questionnaires; Time Factors; Tolvaptan; Treatment Outcome; Ventricular Function, Left

2016
Efficacy and Safety of Tolvaptan in Patients Hospitalized With Acute Heart Failure.
    Journal of the American College of Cardiology, 2017, Mar-21, Volume: 69, Issue:11

    Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Double-Blind Method; Dyspnea; Female; Heart Failure; Humans; Kidney Function Tests; Male; Middle Aged; Prospective Studies; Tolvaptan

2017
Short-Term Effects of Tolvaptan in Patients With Acute Heart Failure and Volume Overload.
    Journal of the American College of Cardiology, 2017, Mar-21, Volume: 69, Issue:11

    Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Double-Blind Method; Dyspnea; Female; Heart Failure; Humans; Male; Middle Aged; Tolvaptan; Water-Electrolyte Imbalance

2017
Effects of tolvaptan on dyspnoea relief from the EVEREST trials.
    European heart journal, 2009, Volume: 30, Issue:18

    Topics: Aged; Benzazepines; Double-Blind Method; Dyspnea; Female; Humans; Male; Pulmonary Atelectasis; Respiratory System Agents; Tolvaptan; Treatment Outcome

2009

Other Studies

3 other study(ies) available for tolvaptan and Dyspnea

ArticleYear
Tolerability of the Intravenously Administered Tolvaptan Prodrug, OPC-61815, in Patients With Congestive Heart Failure Who Have Difficulty With, or Are Incapable of, Oral Intake (TRITON-HF) - A Phase III, Multicenter, Open-Label Trial.
    Circulation journal : official journal of the Japanese Circulation Society, 2022, 06-24, Volume: 86, Issue:7

    Topics: Antidiuretic Hormone Receptor Antagonists; Dyspnea; Edema; Heart Failure; Humans; Prodrugs; Tolvaptan

2022
Chronic Kidney Disease Contributing to Dyspnea in Patients With Heart Failure.
    Journal of the American College of Cardiology, 2017, 07-18, Volume: 70, Issue:3

    Topics: Dyspnea; Heart Failure; Humans; Renal Insufficiency, Chronic; Tolvaptan

2017
Adding High-Dose Spironolactone to Tolvaptan Improves Acute Decompensated Heart Failure Due to Obstructive Hypertrophic Cardiomyopathy and Aortic Stenosis: A Case Report.
    The American journal of case reports, 2019, Jul-12, Volume: 20

    Topics: Acute Disease; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Aortic Valve Stenosis; Cardiomyopathy, Hypertrophic; Drug Therapy, Combination; Dyspnea; Female; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Spironolactone; Tolvaptan

2019